Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Treasury Shares (2020 - 2026)

Climb Bio filings provide 7 years of Treasury Shares readings, the most recent being $207775.0 for Q1 2026.

  • Quarterly Treasury Shares fell 77.13% to $207775.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $207775.0 through Mar 2026, down 77.13% year-over-year, with the annual reading at $207897.0 for FY2025, 83.08% down from the prior year.
  • Treasury Shares hit $207775.0 in Q1 2026 for Climb Bio, roughly flat from $207897.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.2 million in Q3 2024 and bottomed at $149975.0 in Q4 2023.
  • Average Treasury Shares over 5 years is $461140.7, with a median of $219310.0 recorded in 2022.
  • The largest annual shift saw Treasury Shares surged 719.39% in 2024 before it tumbled 83.38% in 2025.
  • Climb Bio's Treasury Shares stood at $177495.0 in 2022, then decreased by 15.5% to $149975.0 in 2023, then surged by 719.39% to $1.2 million in 2024, then crashed by 83.08% to $207897.0 in 2025, then dropped by 0.06% to $207775.0 in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Treasury Shares are $207775.0 (Q1 2026), $207897.0 (Q4 2025), and $207375.0 (Q3 2025).